MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
暂无分享,去创建一个
Y. Sheng | R. Hu | Y. Miao | S. Qi | Jun Zhao | Qin-ping Yang | Qin-ping Yang
[1] Yuan Le,et al. MicroRNA profiling in Chinese children with Henoch‐Schonlein purpura and association between selected microRNAs and inflammatory biomarkers , 2021, Acta paediatrica.
[2] Jia Wei,et al. Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer , 2020, Journal of Cancer.
[3] Yuntao Shi,et al. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer , 2019, International Journal of Clinical Oncology.
[4] Y. Sheng,et al. Identification of blood microRNA alterations in patients with severe active alopecia areata , 2019, Journal of cellular biochemistry.
[5] Fu-bao Liu,et al. Exosomal miR‐1246 derived from human umbilical cord blood mesenchymal stem cells attenuates hepatic ischemia reperfusion injury by modulating T helper 17/regulatory T balance , 2019, IUBMB life.
[6] Guideng Li,et al. MicroRNA-125 in immunity and cancer. , 2019, Cancer letters.
[7] Taichen Lin,et al. miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.
[8] Qian Li,et al. MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway , 2019, Cancer research and treatment : official journal of Korean Cancer Association.
[9] D. Rosmarin,et al. Response to ustekinumab in three pediatric patients with alopecia areata , 2018, Pediatric dermatology.
[10] Ting Wang,et al. MicroRNA‐mediated regulation of T helper type 17/regulatory T‐cell balance in autoimmune disease , 2018, Immunology.
[11] M. Lebwohl,et al. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata , 2018, Archives of Dermatological Research.
[12] H. Morsy,et al. Correlation between serum IL‐17A level and SALT score in patients with alopecia areata before and after NB‐UVB therapy , 2018, Journal of cosmetic dermatology.
[13] B. Lew,et al. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[14] C. Harris,et al. Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246 , 2018, Nature Communications.
[15] H. Kiyono,et al. MicroRNA-mediated dynamic control of mucosal immunity. , 2017, International immunology.
[16] A. Eid,et al. Serum level of interleukin‐17A in patients with alopecia areata and its relationship to age , 2016, International journal of dermatology.
[17] M. Atwa,et al. T‐helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor‐α) in patients with alopecia areata: association with clinical type and severity , 2016, International journal of dermatology.
[18] A. Kerstan,et al. NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells , 2016, Nature Communications.
[19] M. Lebwohl,et al. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism. , 2016, The Journal of allergy and clinical immunology.
[20] Feng Xu,et al. Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata , 2015, The Journal of dermatology.
[21] H. Tan,et al. Reliability and validity assessment of the revised Symptom Checklist 90 for alopecia areata patients in China , 2015, The Journal of dermatology.
[22] S. Reppert,et al. NFATc1 deletion in T lymphocytes inhibits the allergic trait in a murine model of asthma , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[23] T. Niki,et al. Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo. , 2015, International journal of oncology.
[24] M. Lebwohl,et al. Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up , 2015, The British journal of dermatology.
[25] S. Finotto,et al. NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis , 2015, European journal of immunology.
[26] T. Chan,et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus , 2015, Clinical Epigenetics.
[27] Feng Xu,et al. Assessing quality of life in Alopecia areata patients in China , 2015, Psychology, health & medicine.
[28] A. van den Berg,et al. Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs , 2014, Genes and Immunity.
[29] M. Pellegrino,et al. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch , 2013, Cell.
[30] A. Kawada,et al. Alopecia Areata: Infiltration of Th17 Cells in the Dermis, Particularly around Hair Follicles , 2013, Dermatology.
[31] Youcun Qian,et al. MicroRNA in immunity and autoimmunity , 2013, Journal of Molecular Medicine.
[32] A. McDonagh,et al. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012 , 2012, The British journal of dermatology.
[33] Hee-Ryung Cho,et al. Association between IL17A/IL17RA Gene Polymorphisms and Susceptibility to Alopecia Areata in the Korean Population , 2012, Annals of dermatology.
[34] Xiaoping Zhou,et al. MiR-1246: A new link of the p53 family with cancer and Down syndrome , 2012, Cell cycle.
[35] Hua Lu,et al. p53 downregulates Down syndrome‐associated DYRK1A through miR‐1246 , 2011, EMBO reports.
[36] A. Gilhar. Collapse of immune privilege in alopecia areata: coincidental or substantial? , 2010, The Journal of investigative dermatology.
[37] P. Schwartzberg,et al. Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. , 2009, Immunity.
[38] B. Zelger,et al. Expression, localisation and functional activation of NFAT-2 in normal human skin, psoriasis, and cultured keratocytes. , 2009, International journal of clinical and experimental medicine.
[39] Yoshiya Tanaka,et al. Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features. , 2006, Clinical immunology.
[40] S. Gaffen,et al. Crucial Role for Nuclear Factor of Activated T Cells in T Cell Receptor-mediated Regulation of Human Interleukin-17* , 2004, Journal of Biological Chemistry.
[41] A.G. Messenger,et al. Guidelines Guidelines for the management of alopecia areata , 2003 .